77 related articles for article (PubMed ID: 23512591)
21. Microscopic thrombi in glioblastoma multiforme do not predict the development of deep venous thrombosis.
Prayson NF; Angelov L; Prayson RA
Ann Diagn Pathol; 2009 Oct; 13(5):291-6. PubMed ID: 19751904
[TBL] [Abstract][Full Text] [Related]
22. [Thioredoxin reductase--a new target for molecular medical investigations].
Zagrodzki P
Postepy Hig Med Dosw; 2002; 56(2):155-67. PubMed ID: 12107960
[TBL] [Abstract][Full Text] [Related]
23. Thioredoxin, thioredoxin reductase, and alpha-crystallin revive inactivated glyceraldehyde 3-phosphate dehydrogenase in human aged and cataract lens extracts.
Yan H; Lou MF; Fernando MR; Harding JJ
Mol Vis; 2006 Oct; 12():1153-9. PubMed ID: 17093401
[TBL] [Abstract][Full Text] [Related]
24. Molecular bases of thioredoxin and thioredoxin reductase-mediated prooxidant actions of (-)-epigallocatechin-3-gallate.
Zhang H; Cao D; Cui W; Ji M; Qian X; Zhong L
Free Radic Biol Med; 2010 Dec; 49(12):2010-8. PubMed ID: 20951799
[TBL] [Abstract][Full Text] [Related]
25. Glutathione peroxidase, glutathione reductase and protein oxidation in patients with glioblastoma multiforme and transitional meningioma.
Tanriverdi T; Hanimoglu H; Kacira T; Sanus GZ; Kemerdere R; Atukeren P; Gumustas K; Canbaz B; Kaynar MY
J Cancer Res Clin Oncol; 2007 Sep; 133(9):627-33. PubMed ID: 17457608
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of Mammalian thioredoxin reductase by some flavonoids: implications for myricetin and quercetin anticancer activity.
Lu J; Papp LV; Fang J; Rodriguez-Nieto S; Zhivotovsky B; Holmgren A
Cancer Res; 2006 Apr; 66(8):4410-8. PubMed ID: 16618767
[TBL] [Abstract][Full Text] [Related]
27. Blood thioredoxin reductase activity, oxidative stress and hematological parameters in painters and battery workers: relationship with lead and cadmium levels in blood.
Conterato GM; Bulcão RP; Sobieski R; Moro AM; Charão MF; de Freitas FA; de Almeida FL; Moreira AP; Roehrs M; Tonello R; Batista BL; Grotto D; Barbosa F; Garcia SC; Emanuelli T
J Appl Toxicol; 2013 Feb; 33(2):142-50. PubMed ID: 21910133
[TBL] [Abstract][Full Text] [Related]
28. Increased expression of EphA2 correlates with adverse outcome in primary and recurrent glioblastoma multiforme patients.
Wang LF; Fokas E; Bieker M; Rose F; Rexin P; Zhu Y; Pagenstecher A; Engenhart-Cabillic R; An HX
Oncol Rep; 2008 Jan; 19(1):151-6. PubMed ID: 18097589
[TBL] [Abstract][Full Text] [Related]
29. Mechanism-based inactivation of thioredoxin reductase from Plasmodium falciparum by Mannich bases. Implication for cytotoxicity.
Davioud-Charvet E; McLeish MJ; Veine DM; Giegel D; Arscott LD; Andricopulo AD; Becker K; Müller S; Schirmer RH; Williams CH; Kenyon GL
Biochemistry; 2003 Nov; 42(45):13319-30. PubMed ID: 14609342
[TBL] [Abstract][Full Text] [Related]
30. Protein-protein interactions at an enzyme-substrate interface: characterization of transient reaction intermediates throughout a full catalytic cycle of Escherichia coli thioredoxin reductase.
Negri A; Rodríguez-Larrea D; Marco E; Jiménez-Ruiz A; Sánchez-Ruiz JM; Gago F
Proteins; 2010 Jan; 78(1):36-51. PubMed ID: 19585660
[TBL] [Abstract][Full Text] [Related]
31. Expressions of some vital molecules: glioblastoma multiforme versus normal tissues.
Atukeren P; Kemerdere R; Kacira T; Hanimoglu H; Ozlen F; Yavuz B; Tanriverdi T; Gumustas K; Canbaz B
Neurol Res; 2010 Jun; 32(5):492-501. PubMed ID: 20092674
[TBL] [Abstract][Full Text] [Related]
32. Untreated glioblastoma multiforme: increased myo-inositol and glutamine levels in the contralateral cerebral hemisphere at proton MR spectroscopy.
Kallenberg K; Bock HC; Helms G; Jung K; Wrede A; Buhk JH; Giese A; Frahm J; Strik H; Dechent P; Knauth M
Radiology; 2009 Dec; 253(3):805-12. PubMed ID: 19789222
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of the thioredoxin system in the brain and liver of zebra-seabreams exposed to waterborne methylmercury.
Branco V; Canário J; Holmgren A; Carvalho C
Toxicol Appl Pharmacol; 2011 Mar; 251(2):95-103. PubMed ID: 21168431
[TBL] [Abstract][Full Text] [Related]
34. Diphenyl diselenide and analogs are substrates of cerebral rat thioredoxin reductase: a pathway for their neuroprotective effects.
de Freitas AS; Rocha JB
Neurosci Lett; 2011 Sep; 503(1):1-5. PubMed ID: 21839146
[TBL] [Abstract][Full Text] [Related]
35. Occurrence of thioredoxin reductase in Deinococcus species, the UV resistant bacteria.
Seo HJ; Lee YN
J Microbiol; 2006 Aug; 44(4):461-5. PubMed ID: 16953184
[TBL] [Abstract][Full Text] [Related]
36. LncRNA profile of glioblastoma reveals the potential role of lncRNAs in contributing to glioblastoma pathogenesis.
Han L; Zhang K; Shi Z; Zhang J; Zhu J; Zhu S; Zhang A; Jia Z; Wang G; Yu S; Pu P; Dong L; Kang C
Int J Oncol; 2012 Jun; 40(6):2004-12. PubMed ID: 22446686
[TBL] [Abstract][Full Text] [Related]
37. Plasma Thioredoxin Reductase as a Potential Biomarker for Gynecologic Cancer.
Zhu Y; Hu Y; Shi J; Wei X; Song Y; Tang C; Zhang W
Technol Cancer Res Treat; 2023; 22():15330338231184995. PubMed ID: 37365925
[TBL] [Abstract][Full Text] [Related]
38. Thioredoxin and thioredoxin reductase: current research with special reference to human disease.
Holmgren A; Lu J
Biochem Biophys Res Commun; 2010 May; 396(1):120-4. PubMed ID: 20494123
[TBL] [Abstract][Full Text] [Related]
39. Which glioblastoma multiforme patient will become a long-term survivor? A population-based study.
Scott JN; Rewcastle NB; Brasher PM; Fulton D; MacKinnon JA; Hamilton M; Cairncross JG; Forsyth P
Ann Neurol; 1999 Aug; 46(2):183-8. PubMed ID: 10443883
[TBL] [Abstract][Full Text] [Related]
40. High-resolution genomic copy number profiling of glioblastoma multiforme by single nucleotide polymorphism DNA microarray.
Yin D; Ogawa S; Kawamata N; Tunici P; Finocchiaro G; Eoli M; Ruckert C; Huynh T; Liu G; Kato M; Sanada M; Jauch A; Dugas M; Black KL; Koeffler HP
Mol Cancer Res; 2009 May; 7(5):665-77. PubMed ID: 19435819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
